title: High frequency stimulation and pharmacological inactivation of the subthalamic nucleus reduces 'compulsive' lever-pressing in rats.
abstract: In recent years there have been several attempts to establish high frequency stimulation (HFS) as an additional treatment strategy for obsessive-compulsive disorder (OCD). Two studies reported that bilateral HFS of the subthalamic nucleus (STN) dramatically alleviated compulsions and improved obsessions in three patients with co-morbid Parkinson's disease and OCD. A recent study reported that HFS as well as pharmacological inactivation of the STN alleviate compulsive checking in the quinpirole rat model of OCD. As the quinpirole model is based on a dopaminergic manipulation, the aim of the present study was to test whether HFS and pharmacological inactivation of the STN exert an anti-compulsive effect also in the drug-naive brain, using the signal attenuation rat model of OCD. The main finding of the present study is that both HFS and pharmacological inactivation of the STN exerted an anti-compulsive effect, although the two manipulations differed in their effects on other behavioral measures. These findings support the possibility that HFS of the STN may provide an additional therapeutic strategy for OCD.
authors.affiliation: Department of Psychology, Tel Aviv University, Ramat-Aviv, Tel Aviv 69978, Israel.
authors.forename: Oded
authors.initials: O
authors.lastname: Klavir
authors.forename: Shira
authors.initials: S
authors.lastname: Flash
authors.forename: Christine
authors.initials: C
authors.lastname: Winter
authors.forename: Daphna
authors.initials: D
authors.lastname: Joel
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001522:Behavior, Animal; D003192:Compulsive Behavior / Q000503:physiopathology* / Q000628:therapy*; D003216:Conditioning, Operant / Q000187:drug effects / Q000502:physiology*; D046690:Deep Brain Stimulation / Q000379:methods*; D004195:Disease Models, Animal; D005108:Extinction, Psychological / Q000187:drug effects / Q000502:physiology; D018755:GABA Agonists / Q000494:pharmacology; D008297:Male; D008845:Microinjections / Q000379:methods; D009118:Muscimol / Q000494:pharmacology; D011597:Psychomotor Performance / Q000187:drug effects / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D020531:Subthalamic Nucleus / Q000187:drug effects / Q000502:physiology*; D013997:Time Factors
chemical_list: D018755:GABA Agonists; D009118:Muscimol